Survival Rates of Breast Cancer Among Asian American Women
Overview
This study investigates survival rates of breast cancer among Asian American women, revealing lower mortality rates compared to non-Latina White women. Factors contributing to this observation include lower body mass index and smoking prevalence among Asian females.
Background
Breast cancer is the most frequently diagnosed cancer in Asian American females, yet mortality rates post-diagnosis are lower compared to their White counterparts. Understanding the survival dynamics in this population is crucial, especially as Asian individuals represent a rapidly growing demographic in the U.S.
Data Highlights
The study integrated data from four epidemiological studies to assess all-cause and breast cancer-specific mortality among Asian American women compared to White women.
Key Findings
Asian American women have lower breast cancer mortality rates compared to non-Latina White women.
Higher prevalence of poor prognostic tumor characteristics exists among Asian females, such as ERBB2-positive subtypes.
Mortality rates vary significantly among different Asian ethnicities and nativity status.
Only one U.S. study has previously evaluated breast cancer survival by Asian race and ethnicity, indicating a literature gap.
Clinical Implications
Clinicians should consider the unique sociocultural and lifestyle factors when treating Asian American patients with breast cancer.
Conclusion
The findings highlight the complexity of breast cancer survival among Asian American women.
by Scarlett Lin Gomez, Julie Von Behren, Valerie McGuire, Mi-Ok Kim, Luna Gao, Salma Shariff-Marco, Katherine Lin, Iona Cheng, Marilyn L. Kwan, Anna H. Wu, Esther M. John, Lenora Loo, Allison Kurian, Jocelyn Koo, Lia D’addario, Janise M. Roh, Isaac J. Ergas, Esperanza Castillo, Christine B. Ambrosone, Brittany N. Morey, Lawrence H. Kushi, Song Yao
Harold Burstein, MD, PhD, and Ana C. Garrido-Castro, MD discuss results from the Saci-IO HR+ trial, which were presented at the 2026 ESMO Breast Cancer Congress.
